Q32 Bio
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Q32 Bio's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 83% to $1,156,000. Profit margin reached -9772%. Total operating expenses were $92,680,000.
Profit Margin
| 2017 | 0 | -29.99M | |
|---|---|---|---|
| 2019 | 1.66M | -103.91M | -6237.45% |
| 2020 | 2.70M | -128.69M | -4762.92% |
| 2021 | 33.97M | -37.56M | -110.58% |
| 2022 | 6.65M | -42.80M | -643.65% |
| 2023 | 1.15M | -112.96M | -9771.71% |
QTTB Income Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2017 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 1.15M | 6.65M | 33.97M | 2.70M | 1.66M | 0 |
Cost of revenue | 578K | 2.59M | 9.54M | 0 | 0 | 684.21K |
Gross profit | 578K | 4.05M | 24.42M | 2.70M | 1.66M | -684.21K |
Operating exp. | ||||||
Research and development | 62.00M | 35.81M | 29.92M | 100.39M | 89.39M | 21.37M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 92.68M | 45.87M | 36.69M | 124.06M | 105.29M | 28.97M |
Operating income | -92.10M | -39.22M | -36.69M | -130.26M | -109.94M | -29.65M |
Other income (expenses), net | 5.02M | -3.52M | -324K | 1.56M | 6.02M | -333.36K |
Income before tax | -87.08M | -42.74M | -37.01M | -128.69M | -103.91M | -29.99M |
Income tax expense | 25.88M | 62K | 547K | -1 | 0 | -4 |
Net income | -112.96M | -42.80M | -37.56M | -128.69M | -103.91M | -29.99M |
Earnings per share | ||||||
Basic EPS | -35.16 | -13.42 | -12.23 | -50.46 | -44.41 | -14.42 |
Diluted EPS | -35.16 | -13.42 | -12.23 | -50.46 | -44.41 | -14.42 |